Download Free Medical Clinical Approach to Neonatal Jaundice PowerPoint Presentation

Clinical Approach to Neonatal Jaundice PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical titled "Clinical Approach to Neonatal Jaundice” by Dr. Siddeeg Addow.

This medical is about neonatal jaundice, also known as neonatal hyperbilirubinemia. Neonatal jaundice is a common condition that affects newborn infants. It occurs due to an excess of bilirubin, a yellow pigment that is produced during the breakdown of red blood cells. While mild jaundice is a normal occurrence in newborns, severe cases may require medical attention.

This presentation gives a clinical approach to neonatal jaundice.

Tags : Neonatal Jaundice, neonatal hyperbilirubinemia, bilirubin, red blood cells, Neonatal-Perinatal Medicine, Neonatal-Perinatal Medicine

Published on : Jun 01, 2023 | Views : 592 | Downloads : 11

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Dr. Siddeeg Addow Pediatric Resident Khartoum, Sudan Clinical Approach to Neonatal Jaundice
Slide 2-

CONTENTS: INTRODUCTION PATHOPHYSIOLOGY DIFFERENTIAL DIAGNOSIS HISTORY EXAMINATION INVESTIGATION
Slide 3-

INTRODUCTION Bilirubin is the end product of heme degradation Most of the daily production comes from the breakdown of RBCs in the RES Heme biliverdin bilirubin Bilirubin is released & bound to serum albumin Bilirubin is uptake & conjugated with glucuronic acid Finally conjugated bilirubin is excreted in bile
Slide 4-

PATHOPHYSIOLOGY UNCONJUGATED B. CONJUGATED B. Tightly compounded to s. albumin Normally very small amount is present as albumin free Insoluble in water can not be excreted in urine Toxic Non toxic Water soluble Loosely bound to albumin. Delta fraction
Slide 5-

Both conjugated & unconjugated bilirubin may accumulate systemically & deposit in tissues Normally s. bilirubin level vary b/w 0.3 & 1.2mg/dl. The rate of systemic bilirubin production is = to the rate of hepatic uptake, conjugation & biliray excretion . Jaundice becomes evident when the s.bilirubin levels rise above 2.0 to 2.5mg/dl
Slide 6-

Levels as high as 30 to 40mg/dl can occur with sever disease Jaundice occurs when the = b/w bilirubin production &clearance is disturbed by one or more of the following mechanisms: Excessive production of bilirubin Reduced hepatic uptake Impaired conjugation Decreased hepatocellular excretion Impaired bile flow
Slide 7-

CAUSES OF JAUNDICE
Slide 8-

Excessive production of bilirubin hemolytic anemia's resorption of blood from internal hemor. ineffective erythropoiesis
Slide 9-

Reduced hepatic uptake: drugs some cases of Gilbert syndrome
Slide 10-

Impaired bilirubin conjugation: physiologic jaundice breast milk jaundice genetic deficiency of glcuronosyl transferase decreased expression of glcuronosyl transferase diffuse hepatocellular diseases
Slide 11-

Decrease excretion of conjugated bilirubin: deficiency in canalicular membrane transport drug induced canalicular membrane dysfunction hepatocelluler damage or toxicity
Slide 12-

Decreased intrahepatic bile flow : inflammatory destruction of intrahepatic bile ducts
Slide 13-

Extra hepatic biliary obstruction: gall stone obstruction of biliary tree extra hepatic biliary atresia biliary stricture & choledochal cyst primary sclerosing cholangitis liver fluke infestation carcinoma
Slide 14-

HISTORY onset / duration pain nausea & vomiting loss of weight itching color of stool color of urine past history ttt &family history
Slide 15-

EXAMINATION color of skin severity of jaundice anemia liver spleen gall bladder ascites
Slide 16-

INVESIGATION CBC LFT Prothrombin time Alfa feto proteins UG SG U/S ERCP & PTC Liver biopsy
Slide 17-

The End